Cancer Genetics has appointed Mandar Kulkarni chief technology officer of Cancer Genetics, India. Kulkarni will direct efforts at expanding CG India's technology programs and initiatives with a focus on accelerating development and innovation. He will report to Cancer Genetics CEO Panna Sharma. Kulkarni joins the company from Sandor Lifesciences where he was head of molecular biology and genomics. He was also a senior scientist at M/Z Diagnostics.